Cargando…

Proton therapy in the management of non-Hodgkin lymphoma

Proton therapy (PT) is a highly conformal type of radiation therapy that can target the tumor while sparing dose to surrounding normal tissues. This study reviews a single institution's experience managing patients with non-Hodgkin lymphoma (NHL) treated with PT. Eleven patients with NHL were t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sachsman, Suzanne, Flampouri, Stella, Li, Zuofeng, Lynch, James, Mendenhall, Nancy P., Hoppe, Bradford S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2015
Materias:	Original Articles: Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732409/ https://www.ncbi.nlm.nih.gov/pubmed/25669925 http://dx.doi.org/10.3109/10428194.2015.1014364

Ejemplares similares

Irradiating Residual Disease to 30 Gy with Proton Therapy in Pediatric Mediastinal Hodgkin Lymphoma
por: Hoppe, Bradford S., et al.
Publicado: (2020)

Pulmonary Function after Proton Therapy for Hodgkin Lymphoma
por: O'steen, Lillie, et al.
Publicado: (2019)

Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma
por: Hoppe, B. S., et al.
Publicado: (2017)

Importance of baseline PET/CT imaging on radiation field design and relapse rates in patients with Hodgkin lymphoma
por: Figura, Nick, et al.
Publicado: (2017)

Intrafractional Displacement of Cardiac Substructures Among Patients With Mediastinal Lymphoma or Lung Cancer
por: Guzhva, Lidia, et al.
Publicado: (2019)

Comparative Effectiveness of Proton Therapy versus Photon Radiotherapy in Adolescents and Young Adults for Classical Hodgkin Lymphoma
por: Bates, James E., et al.
Publicado: (2021)

Impact of intrafraction prostate motion on clinical target coverage in proton therapy: A simulation study of dosimetric differences in two delivery techniques
por: Su, Zhong, et al.
Publicado: (2019)

Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer?
por: Bryant, Curtis, et al.
Publicado: (2016)

Image-Guided Hypofractionated Proton Therapy in Early-Stage Non–Small Cell Lung Cancer: A Phase 2 Study
por: Kharod, Shivam M., et al.
Publicado: (2020)

Proton Radiation Therapy After Chemotherapy in the Management of Aggressive Mediastinal Non-Hodgkin Lymphomas: A Particle Therapy Cooperative Group Lymphoma Subcommittee Collaboration
por: Baron, Jonathan A., et al.
Publicado: (2022)

Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin Lymphoma
por: Way, Ashley, et al.
Publicado: (2021)

Does the Incidence of Treatment-Related Toxicity Plateau After Radiation Therapy: The Long-Term Impact of Integral Dose in Hodgkin's Lymphoma Survivors
por: Holtzman, Adam L., et al.
Publicado: (2019)

Erectile Function, Incontinence, and Other Quality of Life Outcomes Following Proton Therapy for Prostate Cancer in Men 60 Years Old and Younger
por: Hoppe, Bradford S, et al.
Publicado: (2012)

Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: Results of two prospective trials
por: Henderson, Randal H., et al.
Publicado: (2013)

Postoperative or Salvage Proton Radiotherapy for Prostate Cancer After Radical Prostatectomy
por: Kharod, Shivam M., et al.
Publicado: (2021)

Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression
por: Kil, Whoon Jong, et al.
Publicado: (2013)

Prognostic factors of radiation dermatitis following passive-scattering proton therapy for breast cancer
por: Liang, Xiaoying, et al.
Publicado: (2018)

A comprehensive dosimetric study of Monte Carlo and pencil‐beam algorithms on intensity‐modulated proton therapy for breast cancer
por: Liang, Xiaoying, et al.
Publicado: (2018)

Normal tissue complication probability models for prospectively scored late rectal and urinary morbidity after proton therapy of prostate cancer
por: Pedersen, Jesper, et al.
Publicado: (2021)

A real-world study of combined modality therapy for early-stage Hodgkin lymphoma: too little treatment impacts outcome
por: Chohan, Karan L., et al.
Publicado: (2022)

Protons Safely Allow Coverage of High-Risk Nodes for Patients with Regionally Advanced Non-Small-Cell Lung Cancer
por: Nichols, R. C., et al.
Publicado: (2011)

Development and Implementation of Proton Therapy for Hodgkin Lymphoma: Challenges and Perspectives
por: Loap, Pierre, et al.
Publicado: (2021)

Dosimetric consequences of image guidance techniques on robust optimized intensity-modulated proton therapy for treatment of breast Cancer
por: Liang, Xiaoying, et al.
Publicado: (2020)

Does Gender Matter in Non-Hodgkin Lymphoma? Differences in Epidemiology, Clinical Behavior, and Therapy
por: Horesh, Nurit, et al.
Publicado: (2014)

Novel Targeted Agents in Hodgkin and Non-Hodgkin Lymphoma Therapy
por: Grover, Natalie S., et al.
Publicado: (2015)

FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
por: Barrington, Sally F., et al.
Publicado: (2017)

Hodgkin's Lymphoma in Children and Adolescents: A Saint Petersburg Hodgkin's Lymphoma Group Study
por: Kulyova, Svetlana A., et al.
Publicado: (2011)

Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma
por: Mailhot Vega, Raymond B., et al.
Publicado: (2021)

Primary adrenal Hodgkin lymphoma
por: Haykal, Tarek, et al.
Publicado: (2019)

Late radiation toxicity in Hodgkin lymphoma patients: proton therapy's potential
por: Toltz, Allison, et al.
Publicado: (2015)

Current Situation of Proton Therapy for Hodgkin Lymphoma: From Expectations to Evidence
por: Loap, Pierre, et al.
Publicado: (2021)

Management of patients with non-Hodgkin’s lymphoma: focus on adoptive T-cell therapy
por: Perna, Serena Kimi, et al.
Publicado: (2015)

The role of motion management and position verification in lymphoma radiotherapy
por: Aznar, Marianne, et al.
Publicado: (2021)

Hodgkin's Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up
por: Alhashmi, Hani, et al.
Publicado: (2019)

Dosimetric characterization of whole brain radiotherapy of pediatric patients using modulated proton beams
por: Jin, Hosang, et al.
Publicado: (2011)

Survival from non-Hodgkin lymphoma in England and Wales up to 2001
por: Johnson, P W M
Publicado: (2008)

Non-Hodgkin's Lymphomas
por: Proctor, S.J.
Publicado: (1994)

Long-term Outcomes from Proton Therapy for Sinonasal Cancers
por: Dagan, Roi, et al.
Publicado: (2021)

SEOM clinical guidelines for the treatment of follicular non-Hodgkin’s lymphoma
por: Provencio Pulla, M., et al.
Publicado: (2015)

Economic impact of disease progression in follicular non-Hodgkin lymphoma
por: Beveridge, Roy, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9lgbp7ivllafi51tnn075oimaa